Literature DB >> 1467782

Barrett's oesophagus.

J F Bartlesman1, W Hameeteman, G N Tÿtgat.   

Abstract

Barrett's oesophagus or columnar lined epithelium of the oesophagus (CLO) is a metaplastic condition associated with excessive gastro-oesophageal reflux. It is found in 15% of patients with reflux oesophagitis. In a detailed study of 115 CLO patients dysplasia was found in 46%; 13.9% were moderate or severe dysplasia, usually found in intestinal type CLO. Fifty patients were endoscoped annually to determine the natural history of the disease. The incidence of adenocarcinoma was 1 in 52 patient-years, a 125-fold excess risk. A dysplasia-carcinoma sequence was seen in the five who developed carcinoma. Patients with early carcinoma were treated surgically with 12% postoperative mortality and 100% survival for 24-70 months.

Entities:  

Mesh:

Year:  1992        PMID: 1467782     DOI: 10.1097/00008469-199206000-00008

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  9 in total

Review 1.  Surveillance in Barrett's oesophagus: a personal view.

Authors:  K K Basu; J S de Caestecker
Journal:  Postgrad Med J       Date:  2002-05       Impact factor: 2.401

Review 2.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

Review 3.  American Gastroenterological Association technical review on the management of Barrett's esophagus.

Authors:  Stuart J Spechler; Prateek Sharma; Rhonda F Souza; John M Inadomi; Nicholas J Shaheen
Journal:  Gastroenterology       Date:  2011-03       Impact factor: 22.682

4.  Ten years' experience of screening patients with Barrett's oesophagus in a university teaching hospital.

Authors:  C E Macdonald; A C Wicks; R J Playford
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

5.  Characteristics of patients with columnar-lined Barrett's esophagus and risk factors for progression to esophageal adenocarcinoma.

Authors:  Kamal E Bani-Hani; Bayan K Bani-Hani; Iain G Martin
Journal:  World J Gastroenterol       Date:  2005-11-21       Impact factor: 5.742

6.  Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux.

Authors:  M Solaymani-Dodaran; R F A Logan; J West; T Card; C Coupland
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

7.  Adenocarcinoma of the esophagus and esophagogastric junction in white men in the United States: alcohol, tobacco, and socioeconomic factors.

Authors:  L M Brown; D T Silverman; L M Pottern; J B Schoenberg; R S Greenberg; G M Swanson; J M Liff; A G Schwartz; R B Hayes; W J Blot
Journal:  Cancer Causes Control       Date:  1994-07       Impact factor: 2.506

8.  Barrett's Esophagus: Emerging Knowledge and Management Strategies.

Authors:  Atul Bhardwaj; Thomas J McGarrity; Douglas B Stairs; Haresh Mani
Journal:  Patholog Res Int       Date:  2012-05-30

9.  Barrett's oesophagus and adenocarcinoma.

Authors:  Christine P J Caygill; Anthony Watson; Pierre Lao-Sirieix; Rebecca C Fitzgerald
Journal:  World J Surg Oncol       Date:  2004-05-07       Impact factor: 2.754

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.